We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$8.68B
AUM Growth
+$1.84B
Cap. Flow
+$1.56B
Cap. Flow %
17.92%
Top 10 Hldgs %
52.47%
Holding
92
New
28
Increased
20
Reduced
13
Closed
21

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$309M
2
IQV icon
IQVIA
IQV
+$279M
3
BEAV
B/E Aerospace Inc
BEAV
+$235M
4
V icon
Visa
V
+$213M
5
WWAV
The WhiteWave Foods Company
WWAV
+$198M

Top Sells

Rank Stock Value
1
LNKD
LinkedIn Corporation
LNKD
+$350M
2
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$228M
3
ITC
ITC HOLDINGS CORP
ITC
+$180M
4
CTSH icon
Cognizant
CTSH
+$174M
5
TDG icon
TransDigm Group
TDG
+$151M

Sector Composition

Rank Sector Weight
1 Healthcare 21.6%
2 Technology 15.94%
3 Communication Services 13.83%
4 Industrials 5.44%
5 Consumer Staples 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLUB
51
DELISTED
Town Sports International Holdings, Inc.
CLUB
$10.2M 0.12%
4,060,082
– –
ABBV icon
52
AbbVie
ABBV
$468B
$10M 0.12%
+160,000
New +$9.77M
AZN icon
53
AstraZeneca
AZN
$257B
$9.97M 0.11%
+182,500
New +$10.4M
HZNP
54
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.87M 0.11%
+610,000
New +$11.1M
NVET
55
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$9.72M 0.11%
2,648,696
– –
GILD icon
56
Gilead Sciences
GILD
$181B
$9.67M 0.11%
+135,000
New +$10M
AMRN
57
Amarin Corp
AMRN
$298M
$6.48M 0.07%
105,250
– –
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$5.84M 0.07%
+90,955
New +$5.6M
BCE icon
59
BCE
BCE
$22.1B
$5.78M 0.07%
133,650
– –
PCO
60
DELISTED
Pendrell Corporation - Class A
PCO
$5.54M 0.06%
8,211
-328
-4% -$217K
CAB
61
DELISTED
Cabela's Inc
CAB
$4.68M 0.05%
80,000
+40,427
+102% +$2.51M
AKAO
62
DELISTED
Achaogen Inc
AKAO
$4.56M 0.05%
+350,000
New +$2.4M
STML
63
DELISTED
Stemline Therapeutics, Inc.
STML
$2.75M 0.03%
+257,500
New +$3.11M
MITL
64
DELISTED
Mitel Networks Corporation
MITL
$2.63M 0.03%
386,267
– –
GCVRZ
65
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.6M 0.03%
6,827,805
+4,000,000
+141% +$1.35M
ILMN icon
66
Illumina
ILMN
$33.1B
$2.43M 0.03%
+19,532
New +$2.63M
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.24M 0.03%
+100,000
New +$1.95M
KDMN
68
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.43M 0.02%
285,620
– –
ACIU icon
69
AC Immune
ACIU
$288M
– –
-15,000
Closed -$247K
ALSN icon
70
Allison Transmission
ALSN
$11B
– –
-3,633,298
Closed -$104M
CI icon
71
Cigna
CI
$73.3B
– –
-115,000
Closed -$15M
CTSH icon
72
Cognizant
CTSH
$27.9B
– –
-3,648,641
Closed -$174M
GD icon
73
General Dynamics
GD
$104B
– –
-822,051
Closed -$128M
KLAC icon
74
KLA
KLAC
$240B
– –
-4,950,000
Closed -$34.5M
MOH icon
75
Molina Healthcare
MOH
$10.5B
– –
-85,000
Closed -$4.96M
1 2
3
4

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2016 Portfolio in Review

As of Q4 2016, Thomas Steyer held 92 positions worth $8.68B, up 27% from $6.84B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Thomas Steyer deployed $1.56B of net new capital in Q4 2016, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was IQVIA: 3,634,880 shares worth $276M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was SBA Communications, an estimated $93.7M trimmed.

  • Thomas Steyer's largest Q4 2016 buy was IQVIA: 3,634,880 shares worth $276M.
  • Thomas Steyer added most to NXP Semiconductors in Q4 2016, an estimated $309M increase.
  • Thomas Steyer's biggest Q4 2016 reduction was SBA Communications, cutting an estimated $93.7M.
  • Thomas Steyer fully exited LinkedIn Corporation in Q4 2016, selling an estimated $350M.
  • Thomas Steyer's ten largest holdings make up 52% of its $8.68B portfolio in Q4 2016.
  • Thomas Steyer opened 28 new positions and closed 21 in Q4 2016.
  • Thomas Steyer's portfolio value rose 27% quarter-over-quarter to $8.68B.

Based on Farallon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.